Reason for request

Re-assessment of the Actual Benefit following the instruction of 7 May 2011 from the Directorate of Social Security and Directorate-General for Health and renewal of inclusion on the list of medicines refundable by National Health Insurance.

Clinical Benefit

Substantial Le service médical rendu par les spécialités ALPRESS LP 2,5 mg et 5 mg reste important.

Contact Us

Évaluation des médicaments

See also

All our publications